196 related articles for article (PubMed ID: 1902334)
1. Bioactivation of aflatoxin B1 by human liver microsomes: role of cytochrome P450 IIIA enzymes.
Ramsdell HS; Parkinson A; Eddy AC; Eaton DL
Toxicol Appl Pharmacol; 1991 May; 108(3):436-47. PubMed ID: 1902334
[TBL] [Abstract][Full Text] [Related]
2. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
[TBL] [Abstract][Full Text] [Related]
3. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.
Gallagher EP; Kunze KL; Stapleton PL; Eaton DL
Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785
[TBL] [Abstract][Full Text] [Related]
4. Modulation of aflatoxin B1 biotransformation in rabbit pulmonary and hepatic microsomes.
Daniels JM; Massey TE
Toxicology; 1992 Aug; 74(1):19-32. PubMed ID: 1514185
[TBL] [Abstract][Full Text] [Related]
5. Biotransformation of aflatoxin B1 in rabbit lung and liver microsomes.
Daniels JM; Liu L; Stewart RK; Massey TE
Carcinogenesis; 1990 May; 11(5):823-7. PubMed ID: 2110514
[TBL] [Abstract][Full Text] [Related]
6. Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver.
Shimada T; Guengerich FP
Proc Natl Acad Sci U S A; 1989 Jan; 86(2):462-5. PubMed ID: 2492107
[TBL] [Abstract][Full Text] [Related]
7. The model Ah-receptor agonist beta-naphthoflavone inhibits aflatoxin B1-DNA binding in vivo in rainbow trout at dietary levels that do not induce CYP1A enzymes.
Takahashi N; Harttig U; Williams DE; Bailey GS
Carcinogenesis; 1996 Jan; 17(1):79-87. PubMed ID: 8565141
[TBL] [Abstract][Full Text] [Related]
8. Oxidation of aflatoxin B1 by bacterial recombinant human cytochrome P450 enzymes.
Ueng YF; Shimada T; Yamazaki H; Guengerich FP
Chem Res Toxicol; 1995 Mar; 8(2):218-25. PubMed ID: 7766804
[TBL] [Abstract][Full Text] [Related]
9. Indole-3-carbinol and beta-naphthoflavone induction of aflatoxin B1 metabolism and cytochromes P-450 associated with bioactivation and detoxication of aflatoxin B1 in the rat.
Stresser DM; Bailey GS; Williams DE
Drug Metab Dispos; 1994; 22(3):383-91. PubMed ID: 8070314
[TBL] [Abstract][Full Text] [Related]
10. Roles of different forms of cytochrome P450 in the activation of the promutagen 6-aminochrysene to genotoxic metabolites in human liver microsomes.
Yamazaki H; Mimura M; Oda Y; Inui Y; Shiraga T; Iwasaki K; Guengerich FP; Shimada T
Carcinogenesis; 1993 Jul; 14(7):1271-8. PubMed ID: 8330339
[TBL] [Abstract][Full Text] [Related]
11. Mouse strain differences in glutathione S-transferase activity and aflatoxin B1 biotransformation.
Borroz KI; Ramsdell HS; Eaton DL
Toxicol Lett; 1991 Sep; 58(1):97-105. PubMed ID: 1910216
[TBL] [Abstract][Full Text] [Related]
12. Aflatoxin B1 hydroxylation by the pregnenolone-16 alpha-carbonitrile-inducible form of rat liver microsomal cytochrome P-450.
Halvorson MR; Safe SH; Parkinson A; Phillips TD
Carcinogenesis; 1988 Nov; 9(11):2103-8. PubMed ID: 3141079
[TBL] [Abstract][Full Text] [Related]
13. 2(3)-tert-butyl-4-hydroxyanisole inhibits oxidative metabolism of aflatoxin B1 in isolated rat hepatocytes.
Ch'ih JJ; Biedrzycka DW; Lin T; Khoo MO; Devlin TM
Proc Soc Exp Biol Med; 1989 Oct; 192(1):35-42. PubMed ID: 2508094
[TBL] [Abstract][Full Text] [Related]
14. In vitro prostaglandin H synthase- and monooxygenase-mediated binding of aflatoxin B1 to DNA in guinea-pig tissue microsomes.
Liu L; Daniels JM; Stewart RK; Massey TE
Carcinogenesis; 1990 Nov; 11(11):1915-9. PubMed ID: 2121380
[TBL] [Abstract][Full Text] [Related]
15. Differential inhibition of aflatoxin B1 oxidation by gestodene action on human liver microsomes.
Kim BR; Oh HS; Kim DH
Biochem Mol Biol Int; 1997 Nov; 43(4):839-46. PubMed ID: 9385444
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of anti-carcinogenesis by indole-3-carbinol. Studies of enzyme induction, electrophile-scavenging, and inhibition of aflatoxin B1 activation.
Fong AT; Swanson HI; Dashwood RH; Williams DE; Hendricks JD; Bailey GS
Biochem Pharmacol; 1990 Jan; 39(1):19-26. PubMed ID: 2105094
[TBL] [Abstract][Full Text] [Related]
17. In vitro metabolism of aflatoxin B1 by normal and tumorous liver tissue from Thailand.
Kirby GM; Wolf CR; Neal GE; Judah DJ; Henderson CJ; Srivatanakul P; Wild CP
Carcinogenesis; 1993 Dec; 14(12):2613-20. PubMed ID: 8269634
[TBL] [Abstract][Full Text] [Related]
18. Expression of human liver cytochrome P450 IIIA4 in yeast. A functional model for the hepatic enzyme.
Renaud JP; Cullin C; Pompon D; Beaune P; Mansuy D
Eur J Biochem; 1990 Dec; 194(3):889-96. PubMed ID: 2269307
[TBL] [Abstract][Full Text] [Related]
19. Species susceptibility to aflatoxin B1 carcinogenesis: comparative kinetics of microsomal biotransformation.
Ramsdell HS; Eaton DL
Cancer Res; 1990 Feb; 50(3):615-20. PubMed ID: 2105159
[TBL] [Abstract][Full Text] [Related]
20. In vitro cytochrome P450 monooxygenase and prostaglandin H-synthase mediated aflatoxin B1 biotransformation in guinea pig tissues: effects of beta-naphthoflavone treatment.
Liu L; Nakatsu K; Massey TE
Arch Toxicol; 1993; 67(6):379-85. PubMed ID: 8215906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
